Skip to main content

Day: January 6, 2021

Providence Announces New Name – ModivCare

DENVER, Jan. 06, 2021 (GLOBE NEWSWIRE) — The Providence Service Corporation (“Providence” or the “Company”) (NASDAQ: PRSC) today announced its new name – ModivCare Inc. The Company’s wholly-owned subsidiary, LogistiCare Solutions, LLC, the nation’s largest provider of non-emergency medical transportation (NEMT), has been renamed ModivCare Solutions, LLC. Effective January 7, 2021, the Company’s common stock will commence trading on the Nasdaq under its new ticker symbol “MODV” and CUSIP 60783X 104.“This strategic shift has allowed us to align our entire organization, from our processes to our people, around our core purpose — Making Connections to Care,” said Daniel Greenleaf, President and CEO of ModivCare. “The pandemic elevated the significance of this pivot, which is why we accelerated a process that may take years to complete...

Continue reading

Sundance Strategies, Inc. announces the soft launch of its’ alternative fixed income asset securitization through participation in the US Capital 2021 educational webinar.

PROVO, UT, Jan. 06, 2021 (GLOBE NEWSWIRE) — US Capital Global announces their 2021 Educational Kick-Off – Alternative Fixed Income Assets + Featuring Sundance Strategies Inc. Please join US Capital Global and Sundance Strategies Inc. in an educational webinar to kick-off the new year and take part in the discussion on alternative fixed income assets! Thursday January 7, 2021 11:00 AM- 11:45 AM MST.About US Capital GlobalUS Capital Global Securities LLC is the FINRA-licensed broker-dealer division of US Capital Global that acts as placement agent for growth-stage companies, projects, and investment funds. Since 1998, the US Capital Global team has been committed to providing small and lower middle market businesses and investors with sophisticated debt, equity, and investment opportunities usually available only to larger middle...

Continue reading

Relay Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled to present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 at 4:30 p.m. ET. The presentation will be webcast live and may be accessed from the Investor page of Relay’s website under Events and Presentations. An archived replay of the webcast will be available for at least 30 days following the presentation.About Relay TherapeuticsRelay Therapeutics (Nasdaq: RLAY) is a clinical-stage precision medicines company transforming the drug discovery process with the goal of bringing life-changing therapies to patients. Built on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, Relay Therapeutics aims to effectively drug protein targets that have previously...

Continue reading

LIZHI INC. Launches “LIZHI PODCAST” App with High-Quality Curated Podcast Content

GUANGZHOU, China, Jan. 06, 2021 (GLOBE NEWSWIRE) — LIZHI INC. (“LIZHI” or “the Company”) (NASDAQ: LIZI), a leading online UGC audio community and interactive audio entertainment platform in China, today announced it has launched a new podcast application, LIZHI PODCAST (the “App”), to engage users with high-quality curated podcast content.The rollout of the App demonstrates LIZHI’s ongoing emphasis on delivering high-quality audio content that resonates with the market and offering a pure podcast listening experience to listeners. The App features premium curated content drawn from LIZHI’s extensive library built over the years as well as new podcasts from selected content creators. Moreover, LIZHI is actively seeking to collaborate with top content creators and celebrities from all walks of life to produce...

Continue reading

Havila Shipping ASA: Settlement agreement with DeepOcean following contract termination

Reference is made to the stock exchange release of 11.12.20 regarding contract termination for the subsea vessel Havila Phoenix.An agreement between companies in Havila Shipping and companies in DeepOcean about full and final settlement between the parties has been signed.The settlement agreement includes both cash settlement and acquisition of ownership to A-frame, Trencher and ROVs previously owned by DeepOcean.Settlement has been executed today.Contacts:CEO Njål Sævik, +47 909 35 722CFO Arne Johan Dale, +47 909 87 706This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Continue reading

Havila Shipping ASA: Avtale med DeepOcean om oppgjør etter terminering av kontrakt

Det vises til børsmelding av 11.12.20 angående terminering av kontrakt med DeepOcean for subseafartøyet Havila Phoenix.Det er inngått avtale mellom selskaper i Havila Shipping og  selskaper i DeepOcean om endelig oppgjør som følge av termineringen av certepartiet.I oppgjøret inngår et kontantvederlag og overtagelse av eiendomsretten til A-ramme, Trencher og ROVer tidligere eiet av DeepOcean.Kontant oppgjør og overtagelse av utstyr i henhold til avtalen er gjennomført i dag.Kontakter:Adm dir Njål Sævik, +47 909 35 722Finansdir Arne Johan Dale, +47 909 87 706Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12

Continue reading

Wearable Medical Devices Market Size Worth USD 195.57 Billion by 2027 at an Astounding 26.4% CAGR by 2027 Owing to Presence of Established Players in North America

Pune, India, Jan. 06, 2021 (GLOBE NEWSWIRE) — The global wearable medical devices market size is expected to showcase considerable growth by reaching USD 195.57 billion by 2027 while exhibiting an astounding CAGR of 26.4% between 2020 and 2027. This is ascribable to factors such as the increasing prevalence of chronic diseases and the growing awareness regarding fitness and wellness amongst the people that is driving the adoption of innovative wearable type of medical devices globally. Fortune Business Insights, in its latest report. The market stood at USD 29.76 billion in 2019 and is likely to gain momentum in the forthcoming years.A wearable medical device is a noninvasive, autonomous device that performs the function of tracking and monitoring the overall health function of the wearer. The wearable technology consists of healthcare...

Continue reading

MRM : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE CONTRACTE AVEC INVEST SECURITIES

            BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE CONTRACTE AVECINVEST SECURITIESMRM présente les informations en date du 31 décembre 2020 relatives au bilan semestriel du contrat de liquidité confié à Invest Securities : Les informations en date du 30 juin 2020 sont rappelées ci-dessous : A propos de MRMMRM est une société d’investissement immobilier cotée qui détient et gère un patrimoine composé majoritairement d’actifs de commerce répartis dans plusieurs régions de France. MRM a pour actionnaire majoritaire la société SCOR SE qui détient 59,9% de son capital. MRM est cotée sur le compartiment C d’Euronext Paris (ISIN : FR0000060196 – code Bloomberg : MRM:FP – code Reuters : MRM.PA). MRM a opté pour le régime SIIC au 1er janvier 2008. Pour plus d’informations :Pièce jointeBilan Semestriel MRM...

Continue reading

Børsmeddelelse nr. 01.2021 Indre værdi pr. 31. december 2020

Bestyrelsen for SmallCap Danmark A/S besluttede med virkning pr. d. 7. november 2019 at overgå fra daglig opgørelse og offentliggørelse af indre værdi til månedlig opgørelse og offentliggørelse. Indre værdi vil offentliggøres senest tre børsdage efter et månedsskifte.Følsomheden på den indre værdi af aktier i SmallCap Danmark A/S overfor ændringer i børskursen på aktier i Rias A/S er d.d.:Med venlig hilsenSmallCap Danmark A/SVedhæftet filAS_01_2021_NAV311220

Continue reading

Sogeclair: Yearly Statement H2 relative to the liquidity contract placed with Societe de bourse Gilbert Dupont

SOGECLAIRBlagnac, France, January 06th 2021-8.50 amYearly Statement H2 relative to the liquidity contract placed with Societe de bourse Gilbert DupontIn respect of the liquidity contract placed by SOGECLAIR with Société de Bourse Gilbert Dupont, as of 31 December 2020, the average liquidity account figures stood at:Number of shares: 980Cash balance: €49,764.13During the 2nd half 2020, it has been trade a total of:You are reminded that at the time of the last half-yearly statement as of 30 June 2020, the average liquidity account figures stood at:Number of shares: 3,028Cash balance: €25,466.61You are reminded that at the time of the setting up of the liquidity contract, the following means have been made available:Number of shares: 3,606Cash balance: €51,114.70 Philippe ROBARDEYPresident and CEOSOGECLAIRSA with capital of €3,098,035Headquarters:...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.